BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6864396)

  • 1. Identification of female carriers of adrenoleukodystrophy.
    Moser HW; Moser AE; Trojak JE; Supplee SW
    J Pediatr; 1983 Jul; 103(1):54-9. PubMed ID: 6864396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenoleukodystrophy: diagnosis and carrier detection by determination of long-chain fatty acids in cultured fibroblasts.
    Tönshoff B; Lehnert W; Ropers HH
    Clin Genet; 1982 Jul; 22(1):25-9. PubMed ID: 7172473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids.
    Moser HW; Moser AB; Frayer KK; Chen W; Schulman JD; O'Neill BP; Kishimoto Y
    Neurology; 1981 Oct; 31(10):1241-9. PubMed ID: 7202134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts.
    Moser HW; Moser AB; Kawamura N; Murphy J; Suzuki K; Schaumburg H; Kishimoto Y
    Ann Neurol; 1980 Jun; 7(6):542-9. PubMed ID: 7436359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carrier detection for adrenoleukodystrophy by high-performance liquid chromatography.
    Sakai T; Antoku Y; Tsukamoto K; Imanishi K; Iwashita H; Gotoh I
    Exp Neurol; 1988 Jun; 100(3):556-62. PubMed ID: 3366206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenoleukodystrophy: clinical and biochemical manifestations in carriers.
    O'Neill BP; Moser HW; Saxena KM; Marmion LC
    Neurology; 1984 Jun; 34(6):798-801. PubMed ID: 6539445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of adrenoleukodystrophy by increased C26:0 fatty acid levels in leukocytes.
    Molzer B; Bernheimer H; Heller R; Toifl K; Vetterlein M
    Clin Chim Acta; 1982 Nov; 125(3):299-305. PubMed ID: 7172439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenoleukodystrophy in Israel: a genetic, clinical and biochemical study.
    Chemke J; Lieberman E; Carmi R; Abarbanel Y; Costeff H; Goldhammer Y; Moser HW
    Isr J Med Sci; 1984 Dec; 20(12):1123-32. PubMed ID: 6097565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging compared with computed tomography in adrenoleukodystrophy.
    Huckman MS; Wong PW; Sullivan T; Zeller P; Geremia GK
    Am J Dis Child; 1986 Oct; 140(10):1001-3. PubMed ID: 3752010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenoleukodystrophy: biochemical procedures in diagnosis, prevention and treatment.
    Watkins PA; Naidu S; Moser HW
    J Inherit Metab Dis; 1987; 10 Suppl 1():46-53. PubMed ID: 3119941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotype heterogeneity among hemizygotes in a family biochemically screened for adrenoleukodystrophy.
    Cotrufo R; Melone MA; Monsurro MR; Di Iorio G; Carella C; Moser HW
    Am J Med Genet; 1987 Apr; 26(4):833-8. PubMed ID: 3591825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adrenoleukodystrophy: significance for genetic counseling of the determination of very long-chain fatty acids and of molecular biology].
    Mathieu M; Aubourg P; Guidoux S; Epelbaum S; Benhamou P; Berquin P; Boudailliez B; Piussan C
    Ann Pediatr (Paris); 1990 Mar; 37(3):157-61. PubMed ID: 2350140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adrenoleukodystrophy in a pair of siblings].
    Rosskamp R; Fichsel H; Röder B; Conzelmann E; Hinrichs U
    Klin Padiatr; 1985; 197(1):61-4. PubMed ID: 2983146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial spastic paraparesis: an adrenoleukodystrophy phenotype?
    O'Neill BP; Swanson JW; Brown FR; Griffin JW; Moser HW
    Neurology; 1985 Aug; 35(8):1233-5. PubMed ID: 4022363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very long-chain fatty acids in erythrocyte membrane sphingomyelin: detection of ALD hemizygotes and heterozygotes.
    Tanaka K; Shimada M; Naruto T; Yamamoto H; Saeki Y; Sai H; Hirose G
    Neurology; 1986 Jun; 36(6):791-5. PubMed ID: 3703284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreasing serum VLCFA levels in ageing X-ALD female carriers.
    Stradomska TJ; Tylki-Szymańska A
    J Inherit Metab Dis; 2001 Dec; 24(8):851-7. PubMed ID: 11916318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of X-linked adrenoleukodystrophy in different biological specimens from ten Portuguese families.
    Jorge P; Quelhas D; Nogueira A
    J Inherit Metab Dis; 1993; 16(1):55-62. PubMed ID: 8387613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple diagnostic method of adrenoleukodystrophy: total fatty acid analysis of erythrocyte membranes.
    Antoku Y; Sakai T; Tsukamoto K; Imanishi K; Ohtsuka Y; Iwashita H; Goto I
    Clin Chim Acta; 1987 Oct; 169(1):121-5. PubMed ID: 3677434
    [No Abstract]   [Full Text] [Related]  

  • 19. [Adrenoleukodystrophy and adrenomyeloneuropathy].
    Masson C
    Presse Med; 1986 Jun; 15(23):1091-3. PubMed ID: 2942890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenoleukodystrophy: clinical, pathological and biochemical findings in two brothers with the onset of cerebral disease in adult life.
    Esiri MM; Hyman NM; Horton WL; Lindenbaum RH
    Neuropathol Appl Neurobiol; 1984; 10(6):429-45. PubMed ID: 6527732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.